Nemes Rush Group’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3
| Closed | -$2 | – | 776 |
|
|
2024
Q4 | $2 | Hold |
3
| – | – | ﹤0.01% | 728 |
|
|
2024
Q3 | $27 | Hold |
3
| – | – | ﹤0.01% | 605 |
|
|
2024
Q2 | $23 | Hold |
3
| – | – | ﹤0.01% | 601 |
|
|
2024
Q1 | $27 | Buy |
+3
| New | +$26 | ﹤0.01% | 663 |
|
|
2023
Q4 | – | Sell |
-4
| Closed | -$22 | – | 700 |
|
|
2023
Q3 | $22 | Hold |
4
| – | – | ﹤0.01% | 651 |
|
|
2023
Q2 | $25 | Buy |
+4
| New | +$26 | ﹤0.01% | 672 |
|